These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 8522471

  • 1. Assay of vancomycin by fluorescence polarisation immunoassay and EMIT in patients with renal failure.
    Saunders NJ, Want SV, Adams DJ.
    J Antimicrob Chemother; 1995 Aug; 36(2):411-5. PubMed ID: 8522471
    [Abstract] [Full Text] [Related]

  • 2. Falsely elevated serum vancomycin concentrations in hemodialysis patients.
    Follin SL, Mueller BA, Scott MK, Carfagna MA, Kraus MA.
    Am J Kidney Dis; 1996 Jan; 27(1):67-74. PubMed ID: 8546140
    [Abstract] [Full Text] [Related]

  • 3. Vancomycin serum concentrations in patients with renal dysfunction: a comparison of fluorescence polarization immunoassay and the enzyme-multiplied immunoassay technique.
    Peckman HJ, Dupuis RE, Sawyer WT, Brouwer KL, Cross RE.
    Ther Drug Monit; 1996 Dec; 18(6):647-53. PubMed ID: 8946660
    [Abstract] [Full Text] [Related]

  • 4. New modified fluorescence polarization immunoassay does not falsely elevate vancomycin concentrations in patients with end-stage renal disease.
    Smith PF, Petros WP, Soucie MP, Copeland KR.
    Ther Drug Monit; 1998 Apr; 20(2):231-5. PubMed ID: 9558140
    [Abstract] [Full Text] [Related]

  • 5. Vancomycin assay performance in patients with acute renal failure.
    Trujillo TN, Sowinski KM, Venezia RA, Scott MK, Mueller BA.
    Intensive Care Med; 1999 Nov; 25(11):1291-6. PubMed ID: 10654216
    [Abstract] [Full Text] [Related]

  • 6. Instability of standard calibrators may be involved in overestimating vancomycin concentrations determined by fluorescence polarization immunoassay.
    Morishige H, Shuto H, Ieiri I, Otsubo K, Oishi R.
    Ther Drug Monit; 1996 Feb; 18(1):80-5. PubMed ID: 8848826
    [Abstract] [Full Text] [Related]

  • 7. Fluorescence polarization immunoassay: can it result in an overestimation of vancomycin in patients not suffering from renal failure?
    Sym D, Smith C, Meenan G, Lehrer M.
    Ther Drug Monit; 2001 Aug; 23(4):441-4. PubMed ID: 11477330
    [Abstract] [Full Text] [Related]

  • 8. Interference with vancomycin fluorescence polarisation immunoassay in a nonuraemic patient.
    Bowhay S, Timms P.
    Ther Drug Monit; 1997 Feb; 19(1):117-9. PubMed ID: 9029761
    [Abstract] [Full Text] [Related]

  • 9. Vancomycin assay performance in patients with end-stage renal disease receiving hemodialysis.
    Kingery JR, Sowinski KM, Kraus MA, Klaunig JE, Mueller BA.
    Pharmacotherapy; 2000 Jun; 20(6):653-6. PubMed ID: 10853620
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Measurement of vancomycin in renally impaired patient samples using a new high-performance liquid chromatography method with vitamin B12 internal standard: comparison of high-performance liquid chromatography, emit, and fluorescence polarization immunoassay methods.
    Hu MW, Anne L, Forni T, Gottwald K.
    Ther Drug Monit; 1990 Nov; 12(6):562-9. PubMed ID: 2275003
    [Abstract] [Full Text] [Related]

  • 13. Accuracy of vancomycin serum concentrations in patients with renal failure.
    Perino LM, Mueller BA.
    Ann Pharmacother; 1993 Nov; 27(7-8):892-3. PubMed ID: 8364273
    [No Abstract] [Full Text] [Related]

  • 14. More information on vancomycin clearance by new hemodialysis membranes.
    Mueller BA, Scott MK, Clark WR.
    Am J Health Syst Pharm; 1996 Jun 01; 53(11):1339-40, 1348. PubMed ID: 8725212
    [No Abstract] [Full Text] [Related]

  • 15. Comparison of high-performance liquid chromatography with fluorescence polarization immunoassay for the analysis of vancomycin in patients with chronic renal failure.
    Najjar TA, al-Dhuwailie AA, Tekle A.
    J Chromatogr B Biomed Appl; 1995 Oct 20; 672(2):295-9. PubMed ID: 8581137
    [Abstract] [Full Text] [Related]

  • 16. Overestimation of serum vancomycin concentrations using a fluorescence polarization immunoassay (Tdx) in preterm neonates.
    Paap CM, Sharpe GL.
    Dev Pharmacol Ther; 1993 Oct 20; 20(3-4):174-9. PubMed ID: 7828450
    [Abstract] [Full Text] [Related]

  • 17. Potential problem with fluorescence polarization immunoassay cross-reactivity to vancomycin degradation product CDP-1: its detection in sera of renally impaired patients.
    Anne L, Hu M, Chan K, Colin L, Gottwald K.
    Ther Drug Monit; 1989 Sep 20; 11(5):585-91. PubMed ID: 2683253
    [Abstract] [Full Text] [Related]

  • 18. Underestimation of rat serum vancomycin concentrations measured by an enzyme-multiplied immunoassay technique and the strategy for its avoidance.
    Konishi H, Iga I, Nagai K.
    Drug Test Anal; 2014 Apr 20; 6(4):350-6. PubMed ID: 23943307
    [Abstract] [Full Text] [Related]

  • 19. Comparison of bioassay, high-performance liquid chromatography, and fluorescence polarization immunoassay for quantitative determination of vancomycin in serum.
    Ristuccia PA, Ristuccia AM, Bidanset JH, Cunha BA.
    Ther Drug Monit; 1984 Apr 20; 6(2):238-42. PubMed ID: 6377600
    [Abstract] [Full Text] [Related]

  • 20. Diagnostic performance of the EMIT-tox benzodiazepine immunoassay, FPIA serum benzodiazepine immunoassay, and radioreceptor assay in suspected acute poisoning.
    Verstraete AG, Belpaire FM, Leroux-Roels GG.
    J Anal Toxicol; 1998 Apr 20; 22(1):27-32. PubMed ID: 9491965
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.